• Live-Dead Bacterial Staining Kit for Nanomaterials

  2026-09-02

  Use the Live-Dead Bacterial Staining Kit to distinguish membrane-intact bacteria from membrane-compromised cells during nanoparticle antibacterial studies. Its two-channel readout adds spatial and mechanistic context to culture-based bacterial viability assay results, helping researchers optimize dose, exposure time, and imaging controls.

• Spatial Lipid Remodeling in Postoperative Cognition

  2026-09-02

  A rat cardiopulmonary bypass model combined with Barnes maze phenotyping, mass spectrometry imaging, enzyme mapping, and electron microscopy to define hippocampal lipid changes associated with postoperative cognitive dysfunction. The study links CA1 lipid remodeling with synaptic abnormalities and reports that intervention with DHA and myriocin reduced the cognitive phenotype, supporting lipid metabolism as a testable target rather than merely a biomarker.

• AT13387 Hsp90 Inhibitor Workflow for Cancer Research

  2026-09-01

  Build a mechanism-driven cancer biology workflow around AT13387, from Hsp90 client-protein loss to apoptosis and cell-release phenotyping. The approach also translates a recent norovirus–NINJ1 discovery into carefully bounded assay controls without confusing viral secretion biology with anticancer mechanism.

• GDC-0941: From PI3K Biology to Translational Strategy

  2026-09-01

  A mechanistic and strategic guide to using GDC-0941 to interrogate PI3K/Akt signaling, therapy resistance, cancer stem cell biology, and translational assay design.

• Triacetin: Workflows for Metabolic and GBM Research

  2026-08-31

  Triacetin, or glyceryl triacetate, supports distinct experimental workflows spanning glioblastoma cytotoxicity, adipogenesis research, and ocular formulation screening. This practical guide connects mechanism-aware assay design with concentration selection, controls, and troubleshooting for more reproducible results.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-08-31

  Cy5 NHS ester(Et) is a water-soluble, amine-reactive fluorescent dye for covalent labeling of proteins, peptides, and other biomolecules. It is suited to aqueous or DMSO-based labeling workflows, but should not be used in ethanol-based protocols or for long-term storage of prepared solutions.

• NU7441 and DNA-PK: From Repair to Translation

  2026-08-30

  NU7441, also known as KU-57788, is more than a potent DNA-PK inhibitor: it is a mechanistic probe for connecting double-strand break repair, cell-cycle behavior, and emerging links between cytosolic DNA and TDP-43 homeostasis. This article outlines a translational framework for using NU7441 in DNA repair research, oncology research, and exploratory neurobiology while distinguishing evidence from hypothesis.

• Erlotinib: A Causal Map of EGFR–SCUBE3 Biology

  2026-08-29

  Erlotinib (NSC 718781) is more than an EGFR inhibitor: it is a practical perturbation tool for separating receptor-proximal signaling from SCUBE3-associated resistance and immune suppression. This article presents an assay framework that connects biochemical potency with translational cancer-model decisions.

• REV1–DHX36 Control of G4 DNA Replication

  2026-08-28

  The 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its two-tiered model clarifies how cells tolerate stabilized G4 structures and provides a mechanistic framework for studying replication stress and DNA damage response signaling.

• Olaparib Nanoparticles for Local Brain Tumor Delivery

  2026-08-28

  The reference study developed a sprayable pectin hydrogel containing PLA-PEG-coated etoposide and olaparib nanocrystals for local delivery after brain-tumor resection. Its findings support a preclinical formulation strategy that combines bioadhesion, sustained drug release, and nanoparticle distribution around a surgical cavity, while stopping short of demonstrating therapeutic efficacy in intracranial tumor models.

• NU7441 (KU-57788) DNA-PK Workflow Guide

  2026-08-27

  Turn DNA-PK inhibition into a controlled workflow for DNA repair research, oncology research, and cell-cycle analysis. This guide connects cancer-cell sensitization assays with a carefully bounded, hypothesis-generating approach to cytosolic-DNA and TDP-43 biology.

• iPSC Platform for Ultrarare Disease Trial Selection

  2026-08-26

  Sequiera et al. developed a patient-specific iPSC platform to prescreen therapies for an ultrarare ECHS1-related Leigh-like syndrome before clinical trial participation. The study shows how disease-relevant cellular models can connect molecular diagnosis, drug response, and longer-term clinical decision-making while also defining important limits for generalization.

• Linoleic Acid: From Membranes to Metabolic Signals

  2026-08-26

  Explore how Linoleic Acid (C18:2(9Z,12Z)) connects membrane behavior, redox biology, and selective translation. This article turns recent fasting research into a practical framework for choosing interpretable cell and erythrocyte assays.

• IR-1061 Near Infrared Fluorescent Dye Workflow

  2026-08-25

  IR-1061 supports OTN-NIR imaging workflows that prioritize deep-tissue contrast, but its hydrophobicity makes formulation design essential. This guide translates polymer-encapsulation findings into practical preparation, assay, optimization, and troubleshooting decisions for biomedical imaging researchers.

• Protease Inhibitor Cocktail EDTA-Free: K1010 Guide

  2026-08-25

  The Protease Inhibitor Cocktail is a 100X DMSO formulation for limiting endogenous proteolysis during protein extraction. Its EDTA-free design supports workflows that require divalent cations, including phosphorylation analysis and selected kinase assays.

8547 records 1/570 page Next 12345 下5页 Last page